Načítá se...
Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach
2019 – Novel Coronavirus (2019-nCOV), enclosed large genome positive-sense RNA virus characterized by crown-like spikes that protrude from their surface, and have a distinctive replication strategy. The 2019-nCOV belongs to the Coronaviridae family, principally consists of virulent pathogens showing...
Uloženo v:
| Vydáno v: | J Biomol Struct Dyn |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7332877/ https://ncbi.nlm.nih.gov/pubmed/32568620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1781694 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|